Samlyn Capital, Llc

13F Holdings History for Nektar Therapeutics - Common Stock, par value $0.0001 per share (NKTR)

Symbol: NKTR on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 0 shares
Security Ownership: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

SAMLYN CAPITAL, LLC ownership in Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR)

2025-05-15 - SAMLYN CAPITAL, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR). This represents 0% percent ownership of the company. In their previous filing dated 2025-02-14, SAMLYN CAPITAL, LLC had reported owning 9.67M shares, indicating a decrease of -100% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
SAMLYN CAPITAL, LLC	0%	-104%		0	-9,667,048	-100%	$0.49	13G/A	3/31/2025	15 May 2025 15:35:36
Samlyn Capital, LLC	5.2%		$4.74M	9.67M			$0.49	13G	12/31/2024	14 Feb 2025 13:49:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
3/31/2025		-0.14%	$0	0	-9,667,048	-100%		Q1 2025
12/31/2024	0.14%	+0.01%	$8.99M	9.67M	+467,097	+5.08%	$0.93	Q4 2024
9/30/2024	0.19%	-0.01%	$12M	9.2M	-257,936	-2.73%	$1.30	Q3 2024
6/30/2024	0.2%	+0.2%	$11.7M	9.46M	+9,457,887	NEW	$1.24	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.